• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES, INC. AOSEPT PLUS/CLEAR CARE PLUS WITH HYDRAGLYDE CLEANING AND DISINFECTING SOLUTION; ACCESSORIES, SOFT LENS PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES, INC. AOSEPT PLUS/CLEAR CARE PLUS WITH HYDRAGLYDE CLEANING AND DISINFECTING SOLUTION; ACCESSORIES, SOFT LENS PRODUCTS Back to Search Results
Catalog Number 00650363AM
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Conjunctivitis (1784); Corneal Ulcer (1796); Dry Eye(s) (1814); Foreign Body Sensation in Eye (1869); Irritation (1941); Itching Sensation (1943); Keratitis (1944); Blurred Vision (2137); Discomfort (2330)
Event Type  Injury  
Manufacturer Narrative
The complaint sample has not returned for evaluation.Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.(b)(4).
 
Event Description
As initially reported by the patient's husband via telephone, the complaint product caused discomfort, irritation and dry eye.It was added that the patient was diagnosed with corneal ulcer in her left eye (os) from using the complaint product.Additional information was received on (b)(6) 2017 via faxed medical records.History of present illness reported that the os had a sudden onset of continued ocular inflammation on the entire white of the eye (conjunctiva).The patient experienced discomfort, blurred vision, foreign body sensation and mild itching.The patient had discontinued wearing contact lenses.It was noted that the patient cleaned her contact lenses with the complaint product on (b)(6) 2017 and felt increasingly ¿foggy¿ vision and irritation on the eye after wearing the contact lenses on (b)(6) 2017.On (b)(6) 2017, the patient wore eyeglasses as she felt significant pain in the morning and experienced irritation with eye redness; on the left side more than the right, upon arriving to work.The patient was taken to an urgent care facility where fluorescein dye was used and she was diagnosed with corneal ulcer.She was prescribed with moxifloxacin eye drops.The patient was seen on (b)(6) 2017 for a follow-up visit and reported that her eye felt much better.Slit-lamp examination noted areas of punctate epithelial keratitis bilaterally, more on the os than the od.The patient was diagnosed with superficial punctate keratitis (spk) on the os and mild spk on the od with no signs of bacterial infection.She was advised to continue with moxifloxacin eye drops for two more days and use preservative free lubricating eye drops four times a day.The patient was instructed to consult again if the symptoms persisted and was given discussion regarding single use contact lens and directions for use.Additional information was received from the consumer on 08/31/2017 via telephone that her symptoms had improved but she was not permitted to return to work.Additional information was received from the patient on 09/06/2017 that the she was cleared to return to work on (b)(6) 2017 because the symptoms were resolved.Additional information was received via faxed medical records on 09/08/2017.It was noted that the patient presented to the urgent care facility with burning left eye and was not able to drive due to watery eye on (b)(6) 2017.The patient reported that she used a pair of contact lens that was soaked for a week prior to the event.The patient stated that she experienced photosensitivity and had tetanus immunization up to date.The patient tried water for treatment but it did not alleviate the symptom.It was confirmed through slit lamp examination that the left eye showed corneal ulcer and fluorescein uptake with conjunctival injection.Wood lamp examination showed that the eye was positive with fluorescein staining uptake and a five millimeter corneal ulceration was noted over the lower central aspect of the left cornea.The patient was prescribed with moxifloxacin 0.5% ophthalmic solution one drop to be applied three times a day for seven days and acetaminophen-codeine 300-30 mg per tablet one tablet to be taken per orem every six hours as needed for pain.The patient was educated about the nature of her eye condition, was given home care instructions and was advised for a follow up visit if condition worsens.
 
Manufacturer Narrative
The complaint product was returned for evaluation and was found to meet manufacturing specifications.A retained sample from the same complaint lot was tested and was found to meet manufacturing specifications.The device history record and sterilization record for this lot have been reviewed and found to be in compliance.The manufacturing review did not indicate that this complaint was due to the manufacturing process.No complaint or manufacturing trend was identified.The root cause could not be determined.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AOSEPT PLUS/CLEAR CARE PLUS WITH HYDRAGLYDE CLEANING AND DISINFECTING SOLUTION
Type of Device
ACCESSORIES, SOFT LENS PRODUCTS
Manufacturer (Section D)
ALCON LABORATORIES, INC.
6201 south freeway
fort worth TX 76134
Manufacturer (Section G)
ALCON LABORATORIES, INC.
6201 south freeway
fort worth TX 76134
Manufacturer Contact
nadia bailey
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8176152230
MDR Report Key6896889
MDR Text Key87464284
Report Number1610287-2017-00062
Device Sequence Number1
Product Code LPN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142284
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Patient Family Member or Friend
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/27/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date01/31/2019
Device Catalogue Number00650363AM
Device Lot Number281618F
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/20/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received11/22/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/01/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Removal/Correction NumberNOT APPLICABLE
Patient Sequence Number1
Treatment
IBUPROFEN; LAMOTRIGINE; PROPANOLOL; SUMATRIPTAN; TETANUS IMMUNIZATION; UNKNOWN BIRTH CONTROL MEDICATION
Patient Outcome(s) Other;
Patient Age28 YR
-
-